tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Agios Pharmaceuticals upgraded to Outperform from Market Perform at Leerink
PremiumThe FlyAgios Pharmaceuticals upgraded to Outperform from Market Perform at Leerink
10d ago
Agios Pharmaceuticals price target lowered to $32 from $54 at BofA
Premium
The Fly
Agios Pharmaceuticals price target lowered to $32 from $54 at BofA
11d ago
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
11d ago
Agios Pharmaceuticals falls -50.1%
PremiumThe FlyAgios Pharmaceuticals falls -50.1%
11d ago
Fulcrum’s pociredir shows promising early efficacy vs. mitapivat, says Leerink
Premium
The Fly
Fulcrum’s pociredir shows promising early efficacy vs. mitapivat, says Leerink
11d ago
Oppenheimer not surprised by Agios data, continues to favor Fulcrum approach
Premium
The Fly
Oppenheimer not surprised by Agios data, continues to favor Fulcrum approach
11d ago
Agios Pharmaceuticals announces new data on mitapivat
PremiumThe FlyAgios Pharmaceuticals announces new data on mitapivat
27d ago
Agios Pharmaceuticals’ Earnings Call: Growth and Challenges
Premium
Company Announcements
Agios Pharmaceuticals’ Earnings Call: Growth and Challenges
29d ago
Agios Pharmaceuticals Reports Q3 2025 Financial Results
Premium
Company Announcements
Agios Pharmaceuticals Reports Q3 2025 Financial Results
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100